DOSSIER · 13F Holders · Q4 2025Healthcare · Pharmaceutical Preparations
KURA
KURA ONCOLOGY INC
232 institutions still hold KURA ONCOLOGY INC as of Q4 2025. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 50127T109·Pharmaceutical Preparations·232 13F holders·last filed Dec 31, 2025
AI Holders Summary · Q4 2025
232 institutions reported KURA in Q4 2025. BVF INC/IL leads at 16.7% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.
Page 1 of 12
212 more holders available. Log in →